Hysteroscopy Report Says “Chronic Endometritis”: What Should IVF Patients Ask?

A pathology report containing “chronic endometritis” can sound like a permanent infection or an explanation for every failed embryo transfer. The reality is more nuanced. Diagnostic criteria and treatment pathways are not uniform in every clinic, and the report needs context. This article focuses on what patients should verify before spending money on repeated procedures or self-prescribed antibiotics.

The similar names describe different conditions. Endometritis concerns inflammation of the uterine lining; endometriosis refers to endometrium-like tissue outside the uterus. A biopsy statement should not be used to infer ovarian cysts or severe pelvic disease. Conversely, a patient may have symptoms of pelvic infection that need direct medical assessment rather than an IVF add-on discussion.

Ask whether the finding came from a hysteroscopic impression, routine histology or an immunohistochemical marker such as CD138. These are not interchangeable. Histology quality, cell counts and clinical context affect interpretation. The report should identify what evidence supports the diagnosis and whether the conclusion is definite or qualified. A positive report does not tell patients to buy a particular antibiotic without assessment.

A prior failed transfer has multiple potential causes, including embryo factors, chance, uterine anatomy and other clinical conditions. Routine invasive testing in every patient is not universally supported by high-quality evidence. A fertility physician should explain whether symptoms, repeated findings or other indications justify this investigation and what the result would change in the transfer plan.

If treatment is prescribed, the clinician should consider allergies, risks, antimicrobial stewardship and whether other causes of infection need evaluation. A follow-up biopsy or test-of-cure is not necessarily required in the same way for everyone. Ask what outcome is being sought before proceeding with more procedures. Heavy bleeding, fever or substantial pelvic pain warrant prompt medical review.

Patients may also be offered immune tests, microbiome panels or personalised transfer timing after an equivocal biopsy. These are separate questions with varying evidence. Review each proposal for benefit, risk, cost and whether it would alter care. A second opinion should examine the actual pathology and embryology records rather than infer a single cause of failed implantation.

HomeIVF is a doctor-led fertility and IVF care-coordination model designed to reduce avoidable clinic journeys, not to relocate embryology into a living room. A medical review or follow-up discussion may be suitable for teleconsultation; selected home blood collection and prescription-based injection support are conditional on individual clinical suitability and confirmed local availability. Required ultrasound scans, sperm preparation, egg retrieval, fertilisation and embryo culture, and embryo transfer remain facility-based. A safe plan identifies the clinician and the facility responsible for every essential step.

HomeIVF may coordinate pathology-record review through a teleconsultation; biopsy, hysteroscopy, scans, laboratory testing and embryo transfer require clinical facilities. Any home medicine support would need prescribing approval and verified serviceability and must not replace follow-up after complications.

A single timeline of symptoms, blood values, scans and medication changes can reveal that a proposed repeat investigation is already available. Ask whether previous results are recent enough and technically appropriate for the current decision. The purpose is not to skip necessary safety tests; it is to avoid extra tests ordered because records were missing. Request a plain-language summary that you can take to another qualified clinician if needed.

A persuasive website should not replace the missing clinical details with a guarantee or a generic package. Before consenting, ask the team to write down the current diagnosis, the uncertainty that remains and the exact information that would cause them to change their recommendation. If the explanation is simply “we always do it this way,” request the reasoning for your own history. A clear answer often prevents unnecessary repeat appointments and tests.

Keep reports with their test dates, units and issuing laboratory, not just cropped screenshots of the highlighted result. Where fertility medicines are involved, add a medication timeline and note any missed or changed dose. Good record organisation reduces accidental contradictions when one clinician reviews another centre’s work. Do not use an automated calculator or AI answer to overwrite the treating doctor’s plan when new symptoms arise.

Convenience matters, but it cannot determine whether a test, medicine or procedure is necessary. A home visit is helpful only if sample handling, professional accountability, privacy and response to abnormal findings are dependable. Patients should know who receives the result and who calls if it requires urgent attention. When a critical scan or procedure is needed, travelling to a qualified facility is part of safe care rather than a failure of the home-supported model.

• What diagnostic criteria support this report?
• Is the finding clinically relevant to my fertility history?
• What is the evidence for the proposed treatment?
• Would a repeat biopsy change the plan?